CoChat

Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain

Demelash, Abeba, Pfannenstiel, Lukas W., Tannenbaum, Charles S., Li, Xiaoxia, Kalady, Matthew F., DeVecchio, Jennifer, Gastman, Brian R. · 2015 · Journal of Biological Chemistry
Cited by 27

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m115.663898

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 36

  1. Beroukhim, 2010, The landscape of somatic copy-number alteration across human cancers, Nature, 463, 899, 10.1038/nature08822 · DOI · Paper page
  2. Placzek, 2010, A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy, Cell Death Dis, 1, e40, 10.1038/cddis.2010.18 · DOI · Paper page
  3. Elkholi, 2011, The role of BH3-only proteins in tumor cell development, signaling, and treatment, Genes Cancer, 2, 523, 10.1177/1947601911417177 · DOI · Paper page
  4. Juin, 2013, Decoding and unlocking the BCL-2 dependency of cancer cells, Nat. Rev. Cancer, 13, 455, 10.1038/nrc3538 · DOI · Paper page
  5. Baggstrom, 2011, A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer, J. Thorac. Oncol, 6, 1757, 10.1097/JTO.0b013e31822e2941 · DOI · Paper page
  6. Ng, 2014, Selective Bcl-2 inhibition to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma, Clin. Adv. Hematol. Oncol, 12, 224
  7. van Delft, 2006, The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized, Cancer Cell, 10, 389, 10.1016/j.ccr.2006.08.027 · DOI · Paper page
  8. Placzek, 2011, Identification of a novel Mcl-1 protein binding motif, J. Biol. Chem, 286, 39829, 10.1074/jbc.M111.305326 · DOI · Paper page
  9. Bolesta, 2012, Inhibition of Mcl-1 promotes senescence in cancer cells: implications for preventing tumor growth and chemotherapy resistance, Mol. Cell. Biol, 32, 1879, 10.1128/MCB.06214-11 · DOI · Paper page
  10. Stewart, 2010, Ubiquitin-independent degradation of antiapoptotic MCL-1, Mol. Cell. Biol, 30, 3099, 10.1128/MCB.01266-09 · DOI
  11. Wei, 2012, Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency, Cancer Cell, 21, 547, 10.1016/j.ccr.2012.02.028 · DOI · Paper page
  12. Petros, 2014, Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein, Bioorg. Med. Chem. Lett, 24, 1484, 10.1016/j.bmcl.2014.02.010 · DOI
  13. Pfannenstiel, 2012, Raiding the pharmacy: genomic screening identifies known chemotherapies as negative regulators of MCL1, Genome Med, 4, 53, 10.1186/gm352 · DOI
  14. Zhong, 2005, Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis, Cell, 121, 1085, 10.1016/j.cell.2005.06.009 · DOI · Paper page
  15. Thomas, 2010, Mcl-1: the molecular regulation of protein function, FEBS Lett, 584, 2981, 10.1016/j.febslet.2010.05.061 · DOI · Paper page
  16. Germain, 2007, The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function, J. Biol. Chem, 282, 32233, 10.1074/jbc.M706408200 · DOI · Paper page
  17. Varadarajan, 2013, Evaluation and critical assessment of putative MCL-1 inhibitors, Cell Death Differ, 20, 1475, 10.1038/cdd.2013.79 · DOI
  18. Bunz, 1998, Requirement for p53 and p21 to sustain G2 arrest after DNA damage, Science, 282, 1497, 10.1126/science.282.5393.1497 · DOI · Paper page
  19. Grabow, 2014, MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice, Blood, 124, 3939, 10.1182/blood-2014-09-601567 · DOI · Paper page
  20. Demelash, 2012, Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway, Mol. Biol. Cell, 23, 2856, 10.1091/mbc.e10-12-1010 · DOI
  21. Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. U.S.A, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
  22. Perciavalle, 2012, Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration, Nat. Cell Biol, 14, 575, 10.1038/ncb2488 · DOI · Paper page
  23. De Biasio, 2007, N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells, J. Biol. Chem, 282, 23919, 10.1074/jbc.M700938200 · DOI
  24. Han, 2004, Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events, J. Biol. Chem, 279, 22020, 10.1074/jbc.M313234200 · DOI
  25. Fire, 2010, Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes, Protein Sci, 19, 507, 10.1002/pro.329 · DOI · Paper page
  26. Warr, 2011, Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site, J. Biol. Chem, 286, 25098, 10.1074/jbc.M111.218321 · DOI
  27. Liu, 2011, A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation, Sci. Signal, 4, ra72, 10.1126/scisignal.2001843 · DOI · Paper page
  28. Staub, 2009, An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types, J. Mol. Med, 87, 633, 10.1007/s00109-009-0467-y · DOI
  29. Belmar, 2015, Small molecule Mcl-1 inhibitors for the treatment of cancer, Pharmacol. Ther, 145, 76, 10.1016/j.pharmthera.2014.08.003 · DOI · Paper page
  30. Song, 2011, The BH3 mimetic ABT-737 induces cancer cell senescence, Cancer Res, 71, 506, 10.1158/0008-5472.CAN-10-1977 · DOI
  31. Haferkamp, 2013, Vemurafenib induces senescence features in melanoma cells, J. Invest. Dermatol, 133, 1601, 10.1038/jid.2013.6 · DOI
  32. Giuliano, 2011, Advances in melanoma senescence and potential clinical application, Pigment Cell Melanoma Res, 24, 295, 10.1111/j.1755-148X.2010.00820.x · DOI
  33. Billard, 2013, BH3 mimetics: status of the field and new developments, Mol. Cancer Ther, 12, 1691, 10.1158/1535-7163.MCT-13-0058 · DOI · Paper page
  34. Blagosklonny, 2001, Unwinding the loop of Bcl-2 phosphorylation, Leukemia, 15, 869, 10.1038/sj.leu.2402134 · DOI
  35. Chang, 1997, Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2, EMBO J, 16, 968, 10.1093/emboj/16.5.968 · DOI · Paper page
  36. Muchmore, 1996, X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death, Nature, 381, 335, 10.1038/381335a0 · DOI · Paper page

Cited by

Metadata

Authors
Demelash, A., Pfannenstiel, L. W., Tannenbaum, C. S., Li, X., Kalady, M. F., DeVecchio, J., & Gastman, B. R.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2015-09
Volume
290
Issue
36
Pages
21962-21975
ISSN
0021-9258
Cited by
27
References
12
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.